Monday, Oct 25, 2021 | Last Update : 01:51 PM IST

biosimilar insulin

Biocon Biologics, Viatris get FDA nod for biosimilar insulin

The company is eligible to have exclusivity for 12 months before the FDA can approve another biosimilar interchangeable to Lantus

30 Jul 2021 2:54 AM

ADVERTISEMENT
ADVERTISEMENT